Ignite Creation Date:
2026-03-26 @ 3:21 PM
Ignite Modification Date:
2026-04-13 @ 7:26 AM
Study NCT ID:
NCT00476827
Status:
TERMINATED
Last Update Posted:
2013-07-17
First Post:
2007-05-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain
Sponsor:
Duke University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-05
Start Date Type:
None
Primary Completion Date:
2011-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-05
Completion Date Type:
ACTUAL
First Submit Date:
2007-05-18
First Submit QC Date:
None
Study First Post Date:
2007-05-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-12-10
Results First Submit QC Date:
None
Results First Post Date:
2013-07-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-07-15
Last Update Post Date:
2013-07-17
Last Update Post Date Type:
ESTIMATED